In Vitro Diagnostics Market is anticipated to cross a value of US$ 129.9 Billion by 2033, at a steady CAGR of 4.8% from 2023 to 2033 | Future Market Insights, Inc.
24 févr. 2023 05h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Feb. 24, 2023 (GLOBE NEWSWIRE) -- The in vitro diagnostics market is likely to thrive at an average CAGR of 4.8% between 2023 and 2033. The market is anticipated to cross a market share...
Vitro Biopharma Appoints Established Life Science Sales Executive to Its Board of Directors
20 févr. 2013 13h25 HE
|
Vitro Diagnostics, Inc.
GOLDEN, Colo., Feb. 20, 2013 (GLOBE NEWSWIRE) -- Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma, simultaneously accepted the resignation of Mr. Erik Van Horn from its Board of Directors and...
Vitro Biopharma Launches New Stem Cell Products to Accelerate Bone Growth
22 janv. 2013 09h51 HE
|
Vitro Diagnostics, Inc.
GOLDEN, Colo., Jan. 22, 2013 (GLOBE NEWSWIRE) -- Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma, announced the launch of a series of products with application to accelerated bone growth,...
Vitro Biopharma Launches Products for Drug Development & Advancement of Joint Regeneration Technology
09 oct. 2012 08h45 HE
|
Vitro Diagnostics, Inc.
GOLDEN, Colo., Oct. 9, 2012 (GLOBE NEWSWIRE) -- Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced the launch of a series of products for use in the development of advanced...
Vitro Biopharma Signs Agreement With StemGenesis for Distribution of Its Stem Cell Products in China
12 sept. 2012 08h40 HE
|
Vitro Diagnostics, Inc.
GOLDEN, Colo., Sept. 12, 2012 (GLOBE NEWSWIRE) -- Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma, announced an agreement with StemGenesis, Inc. (http://www.stemgenesisinc.com) for the...
Vitro Biopharma Strengthens and Expands Its Distribution Agreement With Neuromics
24 juil. 2012 08h55 HE
|
Vitro Diagnostics, Inc.
GOLDEN, Colo., July 24, 2012 (GLOBE NEWSWIRE) -- Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma, announced an expanded relationship with a key distributor of its stem cell-based products,...